The AC asks Congress to direct CMS to establish specific network adequacy standards.
View the top Improvement Activities and Promoting Interoperability measures reported by A/I clinicians.
The College's Strike Force was on Capitol Hill to meet with key legislators.
New rules from CMS aim to make EHI more portable for patients and providers.
Have a voice in improving the coordination of referrals for specialty care!
AC speakers shared updates with attendees at the Annual Meeting in Seattle.
Proposed standards allow for the continued compounding of allergen extract prescription sets for individual patients while including some new requirements.
The College and Academy leadership met with CMS to express serious concerns about the proposed 2019 reductions in Medicare reimbursement.
Some of allergy's top leaders converged on Washington, DC to advocate for issues important to you and your patients.
Allergen extract is restored as a separate section of the proposed chapter.
Update on USP 797 and FDA activities related to compounding of patient-specific allergen vials for immunotherapy
The latest from the roundtable on the potential impact of proposed changes to USP 797.
We've provided comments to USP acknowledging that proposed standards for the in-office compounding of extracts are reasonable and acceptable.
An advisory was issued from the Centers for Medicare and Medicaid Services.
Advocacy Council of the ACAAI to oppose proposed 2019 Medicare payment reductions for allergy/immunology
CMS has released the proposed Medicare Physician Fee Schedule Rule for 2019, which includes substantial Medicare payment reductions for A/I.
This joint statement by iCAALL calls attention to the impact and relevance of allergy specialists.
The production of venom extracts should not be interrupted due to ALK’s departure from the U.S. market.
ALK will no longer supply venom extracts in the U.S.
Compare 2018 RVUs and payment to 2017 for key allergy CPT codes.
Joint advocacy efforts are successful.